12-49037164-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003482.4(KMT2D):​c.10192A>G​(p.Met3398Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0105 in 1,592,154 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M3398K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0081 ( 8 hom., cov: 32)
Exomes 𝑓: 0.011 ( 93 hom. )

Consequence

KMT2D
NM_003482.4 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: 1.35

Publications

17 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006613195).
BP6
Variant 12-49037164-T-C is Benign according to our data. Variant chr12-49037164-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94135.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00811 (1235/152352) while in subpopulation NFE AF = 0.0124 (844/68034). AF 95% confidence interval is 0.0117. There are 8 homozygotes in GnomAd4. There are 597 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1235 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2DNM_003482.4 linkc.10192A>G p.Met3398Val missense_variant Exon 35 of 55 ENST00000301067.12 NP_003473.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2DENST00000301067.12 linkc.10192A>G p.Met3398Val missense_variant Exon 35 of 55 5 NM_003482.4 ENSP00000301067.7

Frequencies

GnomAD3 genomes
AF:
0.00813
AC:
1237
AN:
152234
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00207
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00366
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.0191
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0124
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00879
AC:
2117
AN:
240902
AF XY:
0.00897
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.00230
Gnomad ASJ exome
AF:
0.00502
Gnomad EAS exome
AF:
0.000727
Gnomad FIN exome
AF:
0.0149
Gnomad NFE exome
AF:
0.0140
Gnomad OTH exome
AF:
0.00907
GnomAD4 exome
AF:
0.0108
AC:
15489
AN:
1439802
Hom.:
93
Cov.:
32
AF XY:
0.0107
AC XY:
7610
AN XY:
712170
show subpopulations
African (AFR)
AF:
0.00142
AC:
47
AN:
33106
American (AMR)
AF:
0.00255
AC:
111
AN:
43600
Ashkenazi Jewish (ASJ)
AF:
0.00535
AC:
135
AN:
25248
East Asian (EAS)
AF:
0.000459
AC:
18
AN:
39196
South Asian (SAS)
AF:
0.00229
AC:
194
AN:
84778
European-Finnish (FIN)
AF:
0.0154
AC:
812
AN:
52882
Middle Eastern (MID)
AF:
0.00176
AC:
10
AN:
5694
European-Non Finnish (NFE)
AF:
0.0124
AC:
13593
AN:
1096036
Other (OTH)
AF:
0.00960
AC:
569
AN:
59262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
938
1876
2815
3753
4691
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00811
AC:
1235
AN:
152352
Hom.:
8
Cov.:
32
AF XY:
0.00801
AC XY:
597
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41594
American (AMR)
AF:
0.00366
AC:
56
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.00173
AC:
9
AN:
5188
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4830
European-Finnish (FIN)
AF:
0.0191
AC:
203
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0124
AC:
844
AN:
68034
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
69
137
206
274
343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0106
Hom.:
19
Bravo
AF:
0.00709
TwinsUK
AF:
0.00674
AC:
25
ALSPAC
AF:
0.0132
AC:
51
ESP6500AA
AF:
0.00120
AC:
5
ESP6500EA
AF:
0.0119
AC:
101
ExAC
AF:
0.00941
AC:
1139
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Aug 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30459467, 30107592, 24728327, 24633898) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2D: BP4, BS1, BS2 -

Nov 01, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Kabuki syndrome 1 Benign:4
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 16, 2015
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 26, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Jun 04, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 17, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kabuki syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
12
DANN
Benign
0.88
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.022
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.0066
T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
0.55
N
PhyloP100
1.4
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.27
Sift
Uncertain
0.0020
D
Polyphen
0.0
B
Vest4
0.70
MVP
0.43
MPC
0.15
ClinPred
0.013
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.51
gMVP
0.50
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75937132; hg19: chr12-49430947; COSMIC: COSV56422093; COSMIC: COSV56422093; API